These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38939464)

  • 1. The Art of Planning a Left Atrial Appendage Closure: Will Computational Modeling Simplify the Intervention?
    Korsholm K; Nielsen-Kudsk JE
    JACC Adv; 2022 Dec; 1(5):100138. PubMed ID: 38939464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short term outcome after left atrial appendage occlusion with the AMPLATZER Amulet and WATCHMAN device: results from the ORIGINAL registry (saxOnian RegIstry analyzinG and followINg left atrial Appendage cLosure).
    Kretzler L; Mues C; Wunderlich C; Langbein A; Spitzer SG; Gerk U; Schellong S; Ketteler T; Neuser H; Schwefer M; Strasser R; Ibrahim K; Schoen S; Christoph M
    BMC Cardiovasc Disord; 2022 Jun; 22(1):271. PubMed ID: 35710343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and Rationale of the Swiss-Apero Randomized Clinical Trial: Comparison of Amplatzer Amulet vs Watchman Device in Patients Undergoing Left Atrial Appendage Closure.
    Galea R; De Marco F; Aminian A; Meneveau N; Anselme F; Gräni C; Huber AT; Teiger E; Iriart X; Angelillis M; Brugger N; Spirito A; Corpataux N; Franzone A; Vranckx P; Fischer U; Pedrazzini G; Bedogni F; Windecker S; Räber L; Valgimigli M
    J Cardiovasc Transl Res; 2021 Oct; 14(5):930-940. PubMed ID: 33884564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Propensity-Matched Comparison of Oral Anticoagulation Versus Antiplatelet Therapy After Left Atrial Appendage Closure With WATCHMAN.
    Søndergaard L; Wong YH; Reddy VY; Boersma LVA; Bergmann MW; Doshi S; Kar S; Sievert H; Wehrenberg S; Stein K; Holmes DR
    JACC Cardiovasc Interv; 2019 Jun; 12(11):1055-1063. PubMed ID: 31171282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FEops HEARTguide Patient-Specific Computational Simulations for WATCHMAN FLX Left Atrial Appendage Closure: A Retrospective Study.
    Ranard LS; Vahl TP; Sommer R; Ng V; Leb J; Lehenbauer K; Sitticharoenchai P; Khalique O; Hamid N; De Beule M; Bavo A; Hahn RT
    JACC Adv; 2022 Dec; 1(5):100139. PubMed ID: 38939468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computed Tomography Scan Evidence for Left Atrial Appendage Short-Term Remodeling Following Percutaneous Occlusion: Impact of Device Oversizing.
    Mahmoudi K; Galea R; Elhadad S; Temperli F; Sebag F; Gräni C; Rezine Z; Roten L; Landolff Q; Brugger N; Masri A; Räber L; Amabile N
    J Am Heart Assoc; 2023 Sep; 12(17):e030037. PubMed ID: 37609989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating Real-World Clinical Outcomes in Atrial Fibrillation Patients Receiving the WATCHMAN Left Atrial Appendage Closure Technology: Final 2-Year Outcome Data of the EWOLUTION Trial Focusing on History of Stroke and Hemorrhage.
    Boersma LV; Ince H; Kische S; Pokushalov E; Schmitz T; Schmidt B; Gori T; Meincke F; Protopopov AV; Betts T; Mazzone P; Foley D; Grygier M; Sievert H; De Potter T; Vireca E; Stein K; Bergmann MW;
    Circ Arrhythm Electrophysiol; 2019 Apr; 12(4):e006841. PubMed ID: 30939908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Left atrial appendage closure with the Watchman device in patients with a contraindication for oral anticoagulation: the ASAP study (ASA Plavix Feasibility Study With Watchman Left Atrial Appendage Closure Technology).
    Reddy VY; Möbius-Winkler S; Miller MA; Neuzil P; Schuler G; Wiebe J; Sick P; Sievert H
    J Am Coll Cardiol; 2013 Jun; 61(25):2551-6. PubMed ID: 23583249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Device-Related Thrombus After Left Atrial Appendage Closure: Incidence, Predictors, and Outcomes.
    Dukkipati SR; Kar S; Holmes DR; Doshi SK; Swarup V; Gibson DN; Maini B; Gordon NT; Main ML; Reddy VY
    Circulation; 2018 Aug; 138(9):874-885. PubMed ID: 29752398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term safety and efficacy of left atrial appendage closure with the WATCHMAN device in patients with small left atrial appendage ostia.
    Venkataraman G; Strickberger SA; Doshi S; Ellis CR; Lakkireddy D; Whalen SP; Cuoco F
    J Cardiovasc Electrophysiol; 2018 Jan; 29(1):17-21. PubMed ID: 28877379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Added Value of Preprocedural Cardiac Computed Tomography in Planning Left Atrial Appendage Closure With the Watchman FLX Device.
    Kassab J; Nakhla S; Miyasaka RL; Saliba W; Ghobrial J; Wazni O; Kapadia SR; Kanj M; Harb SC
    Struct Heart; 2023 Sep; 7(5):100188. PubMed ID: 37745676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility of left atrial appendage device closure following chronically failed surgical ligation.
    Ellis CR; Metawee M; Piana RN; Bennett JM; Pretorius M; Deegan RJ
    Heart Rhythm; 2019 Jan; 16(1):12-17. PubMed ID: 30012348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amulet or Watchman Device for Percutaneous Left Atrial Appendage Closure: Primary Results of the SWISS-APERO Randomized Clinical Trial.
    Galea R; De Marco F; Meneveau N; Aminian A; Anselme F; Gräni C; Huber AT; Teiger E; Iriart X; Babongo Bosombo F; Heg D; Franzone A; Vranckx P; Fischer U; Pedrazzini G; Bedogni F; Räber L; Valgimigli M
    Circulation; 2022 Mar; 145(10):724-738. PubMed ID: 34747186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amulet device implantation following incomplete left atrial appendage closure with Watchman legacy device.
    Yoon SH; Elgendy AY; Dallan LAP; Filby SJ
    Catheter Cardiovasc Interv; 2024 Jan; 103(1):226-229. PubMed ID: 37870093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Peridevice Leak on 5-Year Outcomes After Left Atrial Appendage Closure.
    Dukkipati SR; Holmes DR; Doshi SK; Kar S; Singh SM; Gibson D; Price MJ; Natale A; Mansour M; Sievert H; Houle VM; Allocco DJ; Reddy VY
    J Am Coll Cardiol; 2022 Aug; 80(5):469-483. PubMed ID: 35902169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of Amulet Left Atrial Appendage Occluder and Watchman Device for Left Atrial Appendage Closure in Patients With Atrial Fibrillation.
    Sawaya F; Abi-Saleh B; Hoteit A; Jdaidany J; Moumneh MB; Harbieh B; Khoury M; Aramouni S; Abdulhai F; Refaat M
    Cureus; 2024 Mar; 16(3):e55531. PubMed ID: 38576630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Procedure Volume and Outcomes With WATCHMAN Left Atrial Appendage Occlusion.
    Friedman DJ; Du C; Zimmerman S; Tan Z; Lin Z; Vemulapalli S; Kosinski AS; Piccini JP; Pereira L; Minges KE; Faridi KF; Masoudi FA; Curtis JP; Freeman JV
    Circ Cardiovasc Interv; 2024 Jun; 17(6):e013466. PubMed ID: 38889251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient-Level Analysis of Watchman Left Atrial Appendage Occlusion in Practice Versus Clinical Trials.
    Friedman DJ; Du C; Wang Y; Agarwal V; Varosy PD; Masoudi FA; Holmes DR; Reddy VY; Price MJ; Curtis JP; Freeman JV
    JACC Cardiovasc Interv; 2022 May; 15(9):950-961. PubMed ID: 35512918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Additive Value of Preprocedural Computed Tomography Planning Versus Stand-Alone Transesophageal Echocardiogram Guidance to Left Atrial Appendage Occlusion: Comparison of Real-World Practice.
    So CY; Kang G; Villablanca PA; Ignatius A; Asghar S; Dhillon D; Lee JC; Khan A; Singh G; Frisoli TM; O'Neill BP; Eng MH; Song T; Pantelic M; O'Neill WW; Wang DD
    J Am Heart Assoc; 2021 Sep; 10(17):e020615. PubMed ID: 34398676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial.
    Holmes DR; Kar S; Price MJ; Whisenant B; Sievert H; Doshi SK; Huber K; Reddy VY
    J Am Coll Cardiol; 2014 Jul; 64(1):1-12. PubMed ID: 24998121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.